Pancreatic islet cell transplantation: Update and new developments

Nutrition in Clinical Practice

Volumn 22, Issue 5, 2007, Pages 485-493

  Onaca, Nicholas ^a   Naziruddin, Bashoo ^a   Matsumoto, Shinichi ^b   Noguchi, Hirofumi ^b   Klintmalm, Goran B ^a   Levy, Marlon F ^b  

^a BAYLOR HEALTH CARE SYSTEM   (United States)

^b Baylor All Saints Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; INSULIN;

ACNE; ALBUMINURIA; AUTOTRANSPLANTATION; CHRONIC PANCREATITIS; DIARRHEA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDEMA; GLYCEMIC CONTROL; GRAFT REJECTION; GRAFT SURVIVAL; GYNECOLOGIC DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; LIVING DONOR; MOUTH ULCER; NEPHROTOXICITY; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGAN PRESERVATION; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; PROPHYLAXIS; REVIEW; GLUCOSE BLOOD LEVEL; METABOLISM; METHODOLOGY; PANCREAS TRANSPLANTATION; RISK FACTOR; SECRETION; TRANSPLANTATION; TREATMENT OUTCOME;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; GRAFT SURVIVAL; HUMANS; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; PANCREAS TRANSPLANTATION; RISK FACTORS; TISSUE AND ORGAN HARVESTING; TISSUE AND ORGAN PROCUREMENT; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 38749147309     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0115426507022005485     Document Type: Review

References (106)

1. Onaca N, Klintmalm GB, Levy MF. Pancreatic islet cell transplantation: a treatment strategy for type I diabetes mellitus. Nutr Clin Pract. 2004;19:154-164.
2. Korsgren O, Nilsson B, Berne C, et al. Current status of clinical islet transplantation. Transplantation. 2005;79:1289-1293.
3. Ricordi C. Islet transplantation: a brave new world. Diabetes. 2003;52:1595-1603.
4. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230-238.
5. Cohen DJ, St Martin L, Christensen LL, Bloom RD, Sung RS. Kidney and pancreas transplantation in the United States, 1995-2004. Am J Transplant. 2006;6(5 pt 2):1153-1169.
6. Ault A. Edmonton's islet success tough to duplicate elsewhere [letter]. Lancet. 2003;361:2054.
7. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006;355:1318-1330.
8. Berney T, Buhler LH, Morel P. Pancreas allocation in the era of islet transplantation. Transpl Int. 2005;18:763-767.
9. Matsumoto I, Sawada T, Nakano M, et al. Improvement in islet yield from obese donors for human islet transplants. Transplantation. 2004;78:880-885.
10. O'Gorman D, Kin T, Murdoch T, et al. The standardization of pancreatic donors for islet isolations. Transplantation. 2005;80:801-806. (Pubitemid 41443763)
11. Frutos MA, Ruiz P, Mansilla JJ. Pancreas donation for islet transplantation. Transplant Proc. 2005;37:1560-1561.
12. Kim SC, Han DJ, Kang CH, et al. Analysis on donor and isolation-related factors of successful isolation of human islet of Langerhans from human cadaveric donors. Transplant Proc. 2005;37:3402-3403.
13. Lee TC, Barshes NR, Brunicardi FC, et al. Procurement of the human pancreas for pancreatic islet transplantation. Transplantation. 2004;78:481-483.
14. Fraker CA, Alejandro R, Ricordi C. Use of oxygenated perfluorocarbon toward making every pancreas count. Transplantation. 2002;74:1811-1812.
15. 2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol. Transplantation. 2002;74:1414-1419.
16. Ricordi C, Fraker C, Szust J, et al. Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution. Transplantation. 2003;75:1524-1527.
17. Hering BJ, Matsumoto I, Sawada T, et al. Impact of two-layer pancreas preservation on islet isolation and transplantation. Transplantation. 2002;74:1813-1816.
18. Kakinoki K, Fujino Y, Suzuki Y, et al. Superiority of the two-layer method before islet isolation confirmed by in vivo viability assessment. Transplantation. 2005;79:1516-1521.
19. Tanioka Y, Sutherland DE, Kuroda Y, et al. Excellence of the two-layer method (University of Wisconsin solution/perfluorochemical) in pancreas preservation before islet isolation. Surgery. 1997;122:435-441.
20. Witkowski P, Liu Z, Guo Q, et al. Two-layer method in shortterm pancreas preservation for successful islet isolation. Transplant Proc. 2005;37:3398-3401.
21. Tanaka T, Suzuki Y, Tanioka Y, et al. Possibility of islet transplantation from a nonheartbeating donor pancreas resuscitated by the two-layer method. Transplantation. 2005;80:738-742.
22. Kin T, Mirbolooki M, Salehi P, et al. Islet isolation and transplantation outcomes of pancreas preserved with University of Wisconsin solution versus two-layer method using preoxygenated perfluorocarbon. Transplantation. 2006;82:1286-1290.
23. Sawada T, Matsumoto I, Nakano M, Kirchhof N, Sutherland DE, Hering BJ. Improved islet yield and function with ductal injection of University of Wisconsin solution before pancreas preservation. Transplantation. 2003;75:1965-1969.
24. Matsumoto S, Tanaka K. Pancreatic islet cell transplantation using non-heart-beating donors (NHBDs). J Hepatobiliary Pancreat Surg. 2005;12:227-230.
25. Matsumoto S, Okitsu T, Iwanaga Y, et al. Successful islet transplantation from nonheartbeating donor pancreata using modified Ricordi islet isolation method. Transplantation. 2006;82:460-465.
26. Noguchi H, Iwanaga Y, Okitsu T, Nagata H, Yonekawa Y, Matsumoto S. Evaluation of islet transplantation from non-heart beating donors. Am J Transplant. 2006;6:2476-2482.
27. Noguchi H, Ueda M, Nakai Y, et al. Modified two-layer preservation method (M-Kyoto/PFC) improves islet yields in islet isolation. Am J Transplant. 2006;6:496-504.
28. Chen F, Nakamura T, Wada H. Development of new organ preservation solutions in Kyoto University. Yonsei Med J. 2004;45:1107-1114.
29. Ricordi C, Lacy PE, Scharp DW. Automated islet isolation from human pancreas. Diabetes. 1989;38(Suppl 1):140-142.
30. Linetsky E, Bottino R, Lehmann R, Alejandro R, Inverardi L, Ricordi C. Improved human islet isolation using a new enzyme blend, liberase. Diabetes. 1997;46:1120-1123.
31. Matsumoto S, Noguchi H, Yonekawa Y, et al. Pancreatic islet transplantation for treating diabetes. Expert Opin Biol Ther. 2006;6:23-37.
32. Matsumoto S, Rigley TH, Reems JA, Kuroda Y, Stevens RB. Improved islet yields from Macaca nemestrina and marginal human pancreata after two-layer method preservation and endogenous trypsin inhibition. Am J Transplant. 2003;3:53-63.
33. Hering BJ, Kandaswamy R, Harmon JV, et al. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant. 2004;4:390-401.
34. Gaber AO, Fraga DW, Callicutt CS, Gerling IC, Sabek OM, Kotb MY. Improved in vivo pancreatic islet function after prolonged in vitro islet culture. Transplantation. 2001;72:1730-1736.
35. Fraga DW, Gaber AO, Kotb M. Long-term culture and maintenance of human islets of Langerhans in Memphis serum-free media. Methods Mol Med. 2005;107:303-311.
36. Matsumoto S, Goel S, Qualley S, Strong DM, Reems JA. A comparative evaluation of culture conditions for short-term maintenance (<24 hr) of human islets isolated using the Edmonton protocol. Cell Tissue Bank. 2003;4:85-93.
37. Matsumoto S, Yamada Y, Okitsu T, et al. Simple evaluation of engraftment by secretory unit of islet transplant objects for living donor and cadaveric donor fresh or cultured islet transplantation. Transplant Proc. 2005;37:3435-3437.
38. Ricordi C, Gray DW, Hering BJ, et al. Islet isolation assessment in man and large animals. Acta Diabetol Lat. 1990;27:185-195.
39. Gaber AO, Fraga D, Kotb M, Lo A, Sabek O, Latif K. Human islet graft function in NOD-SCID mice predicts clinical response in islet transplant recipients. Transplant Proc. 2004;36:1108-1110.
40. Ichii H, Inverardi L, Pileggi A, et al. A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant. 2005;5:1635-1645.
41. Papas KK, Colton CK, Nelson RA, et al. Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice. Am J Transplant. 2007;7:707-713.
42. Goto M, Holgersson J, Kumagai-Braesch M, Korsgren O. The ADP/ATP ratio: a novel predictive assay for quality assessment of isolated pancreatic islets. Am J Transplant. 2006;6:2483-2487.
43. Goss JA, Soltes G, Goodpastor SE, et al. Pancreatic islet transplantation: the radiographic approach. Transplantation. 2003;76:199-203.
44. Casey JJ, Lakey JR, Ryan EA, et al. Portal venous pressure changes after sequential clinical islet transplantation. Transplantation. 2002;74:913-915.
45. Villiger P, Ryan EA, Owen R, et al. Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution. Am J Transplant. 2005;5:2992-2998.
46. Owen RJ, Ryan EA, O'Kelly K, et al. Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects. Radiology. 2003;229:165-170.
47. Brennan DC, Shannon MB, Koch MJ, Polonsky KS, Desai N, Shapiro J. Portal vein thrombosis complicating islet transplantation in a recipient with the factor V Leiden mutation. Transplantation. 2004;78:172-173.
48. Markmann JF, Rosen M, Siegelman ES, et al. Magnetic resonance-defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival? Diabetes. 2003;52:1591-1594.
49. Bhargava R, Senior PA, Ackerman TE, et al. Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes. 2004;53:1311-1317.
50. Hafiz MM, Faradji RN, Froud T, et al. Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation. Transplantation. 2005;80:1718-1728.
51. Senior PA, Zeman M, Paty BW, Ryan EA, Shapiro AM. Changes in renal function after clinical islet transplantation: four-year observational study. Am J Transplant. 2007;7:91-98.
52. Andres A, Toso C, Morel P, et al. Impact of a sirolimus/tacrolimus-based immunosuppressive regimen on kidney function after islet transplantation. Transplant Proc. 2005;37:1326-1327.
53. Cure P, Pileggi A, Froud T, et al. Alterations of the female reproductive system in recipients of islet grafts. Transplantation. 2004;78:1576-1581.
54. Froud T, Baidal DA, Ponte G, Ferreira JV, Ricordi C, Alejandro R. Resolution of neurotoxicity and beta-cell toxicity in an islet transplant recipient following substitution of tacrolimus with MMF. Cell Transplant. 2006;15:613-620.
55. Cure P, Pileggi A, Faradji RN, et al. Cytomegalovirus infection in a recipient of solitary allogeneic islets. Am J Transplant. 2006;6(5 pt 1):1089-1090.
56. Poggioli R, Froud T, Baidal DA, et al. Hypereosinophilia in an islet transplant recipient. Transplantation. 2005;79:853-854.
57. Ghofaili KA, Fung M, Ao Z, et al. Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes. Transplantation. 2007;83:24-28.
58. Bennet W, Sundberg B, Groth CG, et al. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes. 1999;48:1907-1914.
59. Barshes NR, Wyllie S, Goss JA. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol. 2005;77:587-597.
60. Moberg L, Johansson H, Lukinius A, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet. 2002;360:2039-2045.
61. Piemonti L, Leone BE, Nano R, et al. Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes. 2002;51:55-65.
62. Johansson H, Lukinius A, Moberg L, et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes. 2005;54:1755-1762.
63. Contreras JL, Eckstein C, Smyth CA, et al. Activated protein C preserves functional islet mass after intraportal transplantation: a novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. Diabetes. 2004;53:2804-2814.
64. Contreras JL, Smyth CA, Bilbao G, Young CJ, Thompson JA, Eckhoff DE. 17beta-Estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality. Transplantation. 2002;74:1252-1259.
65. Yang Z, Chen M, Ellett JD, Carter JD, Brayman KL, Nadler JL. Inflammatory blockade improves human pancreatic islet function and viability. Am J Transplant. 2005;5:475-483.
66. Ozmen L, Ekdahl KN, Elgue G, Larsson R, Korsgren O, Nilsson B. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes. 2002;51:1779-1784.
67. Johansson H, Goto M, Dufrane D, et al. Low molecular weight dextran sulfate: a strong candidate drug to block IBMIR in clinical islet transplantation. Am J Transplant. 2006;6:305-312.
68. Hering BJ, Browatzki CC, Schultz A, Bretzel RG, Federlin KF. Clinical islet transplantation: registry report, accomplishments in the past and future research needs. Cell Transplant. 1993;2:269-282.
69. Du CY, Xu EK. Protective effect of glucocorticoid-free immunosuppressive regimen in allogenic islet transplantation. Hepatobiliary Pancreat Dis Int. 2006;5:43-47.
70. Froud T, Ricordi C, Baidal DA, et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant. 2005;5:2037-2046.
71. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes. 2005;54:2060-2069.
72. Frank A, Deng S, Huang X, et al. Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets. Ann Surg. 2004;240:631-640.
73. Hering BJ. Achieving and maintaining insulin independence in human islet transplant recipients. Transplantation. 2005;79:1296-1297.
74. Berney T, Toso C. Monitoring of the islet graft. Diabetes Metab. 2006;32(5 pt 2):503-512.
75. Evgenov NV, Medarova Z, Dai G, Bonner-Weir S, Moore A. In vivo imaging of islet transplantation. Nat Med. 2006;12:144-148.
76. Faradji RN, Monroy K, Riefkohl A, et al. Continuous glucose monitoring system for early detection of graft dysfunction in allogenic islet transplant recipients. Transplant Proc. 2006;38:3274-3276.
77. Faradji RN, Monroy K, Messinger S, et al. Simple measures to monitor beta-cell mass and assess islet graft dysfunction. Am J Transplant. 2007;7:303-308.
78. Fowler M, Virostko J, Chen Z, et al. Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging. Transplantation. 2005;79:768-776.
79. Jirak D, Kriz J, Herynek V, et al. MRI of transplanted pancreatic islets. Magn Reson Med. 2004;52:1228-1233.
80. Kim SJ, Doudet DJ, Studenov AR, et al. Quantitative micro positron emission tomography (PET) imaging for the in vivo determination of pancreatic islet graft survival. Nat Med. 2006;12:1423-1428.
81. Shapiro AM, Hao EG, Lakey JR, et al. Novel approaches toward early diagnosis of islet allograft rejection. Transplantation. 2001;71:1709-1718.
82. Ryan EA, Shandro T, Green K, et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes. 2004;53:955-962.
83. Ryan EA, Paty BW, Senior PA, Lakey JR, Bigam D, Shapiro AM. Beta-score: an assessment of beta-cell function after islet transplantation. Diabetes Care. 2005;28:343-347.
84. Meyer C, Hering BJ, Grossmann R, et al. Improved glucose counterregulation and autonomic symptoms after intraportal islet transplants alone in patients with long-standing type I diabetes mellitus. Transplantation. 1998;66:233-240.
85. Ryan EA, Lakey JR, Paty BW, et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes. 2002;51:2148-2157.
86. Lee TC, Barshes NR, O'Mahony CA, et al. The effect of pancreatic islet transplantation on progression of diabetic retinopathy and neuropathy. Transplant Proc. 2005;37:2263-2265.
87. Fiorina P, Folli F, Zerbini G, et al. Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants. J Am Soc Nephrol. 2003;14:2150-2158.
88. Fiorina P, Folli F, Maffi P, et al. Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: a comparison between kidney-pancreas and kidney-alone transplantation. Transplantation. 2003;75:1296-1301.
89. Fiorina P, Gremizzi C, Maffi P, et al. Islet transplantation is associated with an improvement of cardiovascular function in type 1 diabetic kidney transplant patients. Diabetes Care. 2005;28:1358-1365.
90. Fiorina P, Folli F, Bertuzzi F, et al. Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care. 2003;26:1129-1136.
91. Barshes NR, Vanatta JM, Mote A, et al. Health-related quality of life after pancreatic islet transplantation: a longitudinal study. Transplantation. 2005;79:1727-1730.
92. Poggioli R, Faradji RN, Ponte G, et al. Quality of life after islet transplantation. Am J Transplant. 2006;6:371-378.
93. Drachenberg CB, Klassen DK, Weir MR, et al. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation. 1999;68:396-402.
94. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA. 2005;293:830-835.
95. Goto T, Tanioka Y, Sakai T, et al. Successful islet transplantation from a single pancreas harvested from a young, low-BMI, non-heart-beating cadaver. Transplant Proc. 2005;37:3430-3432.
96. Iwanaga Y, Matsumoto S, Okitsu T, et al. Living donor islet transplantation, the alternative approach to overcome the obstacles limiting transplant. Ann N Y Acad Sci. 2006;1079:335-339.
97. Matsumoto S, Tanaka K, Strong DM, Reems JA. Efficacy of human islet isolation from the tail section of the pancreas for the possibility of living donor islet transplantation. Transplantation. 2004;78:839-843.
98. Matsumoto S, Okitsu T, Iwanaga Y, et al. Insulin independence of unstable diabetic patient after single living donor islet transplantation. Transplant Proc. 2005;37:3427-3429.
99. Matsumoto S, Okitsu T, Iwanaga Y, et al. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet. 2005;365:1642-1644.
100. Matsumoto S, Okitsu T, Iwanaga Y, et al. Follow-up study of the first successful living donor islet transplantation. Transplantation. 2006;82:1629-1633.
101. Tan M, Kandaswamy R, Sutherland DE, Gruessner RW. Laparoscopic donor distal pancreatectomy for living donor pancreas and pancreas-kidney transplantation. Am J Transplant. 2005;5:1966-1970.
102. Ahmed SA, Wray C, Rilo HL, et al. Chronic pancreatitis: recent advances and ongoing challenges. Curr Probl Surg. 2006;43:127-238.
103. Clayton HA, Davies JE, Pollard CA, White SA, Musto PP, Dennison AR. Pancreatectomy with islet autotransplantation for the treatment of severe chronic pancreatitis: the first 40 patients at the Leicester General Hospital. Transplantation. 2003;76:92-98.
104. Rabkin JM, Olyaei AJ, Orloff SL, et al. Distant processing of pancreas islets for autotransplantation following total pancreatectomy. Am J Surg. 1999;177:423-427.
105. Robertson RP, Lanz KJ, Sutherland DE, Kendall DM. Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis. Diabetes. 2001;50:47-50.
106. Ahmad SA, Lowy AM, Wray CJ, et al. Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis. J Am Coll Surg. 2005;201:680-687.